Cargando…

Purinergic and Adenosinergic Signaling in Pancreatobiliary Diseases

Adenosine 5'-triphosphate (ATP), other nucleotides, and the nucleoside analogue, adenosine, all have the capacity to modulate cellular signaling pathways. The cellular processes linked to extracellular purinergic signaling are crucial in the initiation, evolution, and resolution of inflammation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faraoni, Erika Y., Ju, Cynthia, Robson, Simon C., Eltzschig, Holger K., Bailey-Lundberg, Jennifer M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964054/ https://www.ncbi.nlm.nih.gov/pubmed/35360246 http://dx.doi.org/10.3389/fphys.2022.849258

Ejemplares similares

Purinergic signaling in inflammatory renal disease
por: Arulkumaran, Nishkantha, et al.
Publicado: (2013)

Purinergic Signaling in Pulmonary Inflammation
por: Le, Thanh-Thuy T., et al.
Publicado: (2019)

Dysregulation of Adenosinergic Signaling in Systemic and Organ-Specific Autoimmunity
por: Vuerich, Marta, et al.
Publicado: (2019)

Editorial: Purinergic Signaling and Inflammation
por: Yuan, Xiaoyi, et al.
Publicado: (2021)

Regulation of Hypoxic–Adenosinergic Signaling by Estrogen: Implications for Microvascular Injury
por: Cassavaugh, Jessica, et al.
Publicado: (2023)

The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer
por: Strickland, Lincoln N., et al.
Publicado: (2023)

Hypoxia induces purinergic receptor signaling to disrupt endothelial barrier function
por: Raghavan, Somasundaram, et al.
Publicado: (2022)

The adenosinergic signaling in the pathogenesis and treatment of multiple sclerosis
por: Duarte-Silva, Eduardo, et al.
Publicado: (2022)

Eosinophils and Purinergic Signaling in Health and Disease
por: Ferrari, Davide, et al.
Publicado: (2020)

Purinergic Signaling in Neuron-Astrocyte Interactions, Circadian Rhythms, and Alcohol Use Disorder
por: Lindberg, Daniel, et al.
Publicado: (2018)

Purinergic signaling in infection and autoimmune disease
por: Savio, Luiz Eduardo Baggio, et al.
Publicado: (2016)

The Adenosinergic System in Diabetic Retinopathy
por: Vindeirinho, J., et al.
Publicado: (2016)

Notch Signaling Pathway in Pancreatobiliary Tumors
por: Borlak, Francesca, et al.
Publicado: (2021)

Role of Pannexin-1 hemichannels and purinergic receptors in the pathogenesis of human diseases
por: Velasquez, Stephani, et al.
Publicado: (2014)

Ionotropic P2X ATP Receptor Channels Mediate Purinergic Signaling in Mouse Odontoblasts
por: Shiozaki, Yuta, et al.
Publicado: (2017)

Mechanosensitivity of Murine Lung Slowly Adapting Receptors: Minimal Impact of Chemosensory, Serotonergic, and Purinergic Signaling
por: Domnik, Nicolle J., et al.
Publicado: (2022)

The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease
por: Cellai, Lucrezia, et al.
Publicado: (2018)

Control of Gut Inflammation by Modulation of Purinergic Signaling
por: Vuerich, Marta, et al.
Publicado: (2020)

Pathophysiological Role of Purinergic P2X Receptors in Digestive System Diseases
por: An, Qimin, et al.
Publicado: (2021)

The role of adenosinergic pathway in human autoimmune diseases
por: Dong, Ke, et al.
Publicado: (2016)

Adenosinergic Signaling Alters Natural Killer Cell Functional Responses
por: Chambers, Andrea M., et al.
Publicado: (2018)

Colligative Property of ATP: Implications for Enteric Purinergic Neuromuscular Neurotransmission
por: Chaudhury, Arun, et al.
Publicado: (2016)

Carcinoma of Pancreatobiliary Origin
por: Kohoutová, Darina, et al.
Publicado: (2020)

The role of intraductal ultrasonography in pancreatobiliary diseases
por: Sun, Bo, et al.
Publicado: (2016)

Hypoxia signaling in human diseases and therapeutic targets
por: Lee, Jae W., et al.
Publicado: (2019)

Hyperhomocysteinemia and Cardiovascular Disease: Is the Adenosinergic System the Missing Link?
por: Paganelli, Franck, et al.
Publicado: (2021)

Autoimmune Hepatitis: Clinical Review with Insights into the Purinergic Mechanism of Disease
por: Kapila, Nikhil, et al.
Publicado: (2013)

Targeting Purinergic Signaling in the Dynamics of Disease Progression in Sepsis
por: Leite-Aguiar, Raíssa, et al.
Publicado: (2021)

CD73 Is a Major Regulator of Adenosinergic Signalling in Mouse Brain
por: Kulesskaya, Natalia, et al.
Publicado: (2013)

Adenosinergic Signaling as a Key Modulator of the Glioma Microenvironment and Reactive Astrocytes
por: Debom, Gabriela N., et al.
Publicado: (2022)

Purinergic signaling in infectious diseases of the central nervous system
por: Alves, Vinícius Santos, et al.
Publicado: (2020)

Purinergic signaling in the modulation of redox biology
por: Savio, Luiz Eduardo Baggio, et al.
Publicado: (2021)

Role of Image-Enhanced Endoscopy in Pancreatobiliary Diseases
por: Lee, Yun Nah, et al.
Publicado: (2018)

Radiofrequency ablation for pancreatobiliary disease: an updated review
por: Canakis, Andrew, et al.
Publicado: (2023)

The adenosinergic system in cancer: Key therapeutic target
por: Sorrentino, Rosalinda, et al.
Publicado: (2013)

Adenosinergic Pathway: A Hope in the Immunotherapy of Glioblastoma
por: Jin, Ketao, et al.
Publicado: (2021)

Adenosinergic System and Neuroendocrine Syncope: What Is the Link?
por: Guieu, Régis, et al.
Publicado: (2023)

CD73‐generated extracellular adenosine promotes resolution of neutrophil‐mediated tissue injury and restrains metaplasia in pancreatitis
por: O'Brien, Baylee J., et al.
Publicado: (2022)

The CD39-Adenosinergic Axis in the Pathogenesis of Immune and Nonimmune Diabetes
por: Chia, Joanne S. J., et al.
Publicado: (2012)

Antitumoral Action of Resveratrol Through Adenosinergic Signaling in C6 Glioma Cells
por: Sánchez-Melgar, Alejandro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n8h6lm4o4j2jgvroifbvefnbtp